Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
May explain residual Ang II despite ACE inhibition; leaves open whether elastase-2 inhibition improves cardiovascular outcomes.
Becari et al. (2011) studied this question.